Rchr
J-GLOBAL ID:201801004635963224   Update date: Feb. 08, 2024

Maeda Yuka

マエダ ユカ | Maeda Yuka
Affiliation and department:
Job title: Laboratory Head
Research field  (1): Immunology
Research theme for competitive and other funds  (2):
  • 2017 - 2021 Effects of steroids on anti-tumor immune response induced by immune checkpoint inhibitors
  • 2015 - 2017 Development of novel cancer immunotherapy based on the release of immune anergic state
Papers (9):
  • Yuka Maeda, Hisashi Wada, Daisuke Sugiyama, Takuro Saito, Takuma Irie, Kota Itahashi, Kodai Minoura, Susumu Suzuki, Takashi Kojima, Kazuhiro Kakimi, et al. Depletion of central memory CD8+ T cells might impede the antitumor therapeutic effect of Mogamulizumab. Nature communications. 2021. 12. 1. 7280-7280
  • Kodai Minoura, Ko Abe, Yuka Maeda, Hiroyoshi Nishikawa, Teppei Shimamura. CYBERTRACK2.0: zero-inflated model-based cell clustering and population tracking method for longitudinal mass cytometry data. Bioinformatics (Oxford, England). 2021. 37. 11. 1632-1634
  • Atsushi Tanaka, Hiroyoshi Nishikawa, Shinsuke Noguchi, Daisuke Sugiyama, Hiromasa Morikawa, Yoshiko Takeuchi, Danbee Ha, Naoya Shigeta, Toshio Kitawaki, Yuka Maeda, et al. Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells. The Journal of experimental medicine. 2020. 217. 2
  • Takuro Saito, Hiroyoshi Nishikawa, Hisashi Wada, Yuji Nagano, Daisuke Sugiyama, Koji Atarashi, Yuka Maeda, Masahide Hamaguchi, Naganari Ohkura, Eiichi Sato, et al. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers. Nature medicine. 2016. 22. 6. 679-84
  • Yuka Maeda, Hiroyoshi Nishikawa, Daisuke Sugiyama, Danbee Ha, Masahide Hamaguchi, Takuro Saito, Megumi Nishioka, James B Wing, Dennis Adeegbe, Ichiro Katayama, et al. Detection of self-reactive CD8+ T cells with an anergic phenotype in healthy individuals. Science (New York, N.Y.). 2014. 346. 6216. 1536-40
more...
MISC (4):
  • Yuka Maeda, Hiroyoshi Nishikawa, Shimon Sakaguchi. Self-tumor-antigen-specific CD8 T cells were suppressed by regulatory T cells. CANCER IMMUNOLOGY RESEARCH. 2016. 4. 1
  • 杉山 大介, 前田 優香, 西塔 拓郎, 西岡 めぐみ, Ha Danbee, 西川 博嘉, 坂口 志文. 制御性T細胞は腫瘍抗原特異的CD8+T細胞に特徴的なアネルギー状態を誘導する(Regulatory T cells render tumor-antigen specific CD8+ T cells anergic). 日本癌学会総会記事. 2014. 73回. J-1103
  • Yuka Maeda, Takuma Kato, Linan Wang, Daisuke Muraoka, Eiichi Sato, Jedd D. Wolchok, Lloyd J. Old, Hiroshi Shiku, Hiroyoshi Nishikawa. Effects of corticosteroids on tumor immunity induced by anti-CTLA-4 mAb therapy in a mouse model. CANCER RESEARCH. 2010. 70
  • Muraoka Daisuke, Hiroyoshi Nishikawa, Takuma Kato, Linan Wang, Yuka Maeda, Naozumi Harada, Takuro Noguchi, Yutaka Kawakami, Hiroshi Shiku. Peptide vaccine induces apoptosis of antigen-specific CD8(+) T cells. CANCER RESEARCH. 2010. 70
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page